Top Markets
#1 iExec RLC iExec RLC +24.11%
#2 API3 API3 +22.76%
#3 Bedrock Bedrock +20.73%
#4 CyberDEX CyberDEX +19.33%
#5 Radicle Radicle +18.96%
#6 Talus Network Talus Network +18.08%
#7 The Bitcoin Bull The Bitcoin Bull +16.95%
#8 VeThor VeThor +12.86%
#9 Orca Orca +11.81%
#10 Nockchain Nockchain +11.21%
Coin of the day
iExec RLC iExec RLC
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Cell Source, Inc. Cell Source, Inc.

Cell Source, Inc.

CLCS
Classement en actions #28207
Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based... Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based therapies centered on regulating immune tolerance. The company's flagship innovation is its Veto Cell immune system management technology, an advanced immune tolerance platform capable of selectively suppressing specific immune responses. This Veto Cell technology finds application in numerous areas, including enhancing the acceptance of stem cell transplants for conditions like lymphoma, leukemia, and multiple myeloma. Furthermore, it is utilized in treating end-stage kidney disease, various other non-malignant organ diseases, and a spectrum of both cancerous and non-malignant illnesses. Founded in 2012, Cell Source, Inc. maintains its corporate headquarters in New York, New York.
Prix de l'action
$0.4
Dernière synchronisation: 2026-10-02
Capitalisation boursière
$27.18M
Changement (1 jour)
-14.88%
Changement (1 an)
8.11%
Pays
US
Échange Cell Source, Inc. (CLCS)

Catégorie

Healthcare
Le prix CLCS avec la capitalisation boursière de B
Cell Source, Inc. Cell Source, Inc.
CLCS
$0.4
Capitalisation boursière de Cell Source, Inc.(CLCS)
Capitalisation boursière: $27.18M
En October 2026, Cell Source, Inc. a une capitalisation boursière de $27.18M. Cela fait de Cell Source, Inc. la 28207th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Cell Source, Inc. du 2014 au 2026
CLCS par rapport au top 5 des plus populaires stocks
Prix pour CLCS L’actif B La capitalisation boursière de B Résultats
Cell Source, Inc. Cell Source, Inc.
$85,468.45 $27.18M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.807T +21,367,012.68%
Cell Source, Inc. Cell Source, Inc.
$71,980.00 $27.18M
Apple Inc. Apple Inc.
AAPL
$4.891T +17,994,900.12%
Cell Source, Inc. Cell Source, Inc.
$61,479.82 $27.18M
Alphabet Inc. Alphabet Inc.
GOOG
$4.177T +15,369,855.18%
Cell Source, Inc. Cell Source, Inc.
$57,671.08 $27.18M
Microsoft Corporation Microsoft Corporation
MSFT
$3.919T +14,417,670.59%
Cell Source, Inc. Cell Source, Inc.
$40,091.05 $27.18M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.724T +10,022,661.63%